Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
The seven major markets comprise of the five major European markets (France, Germany, Italy, Spain and the UK), Japan and the US.
Fleming, D. M., Sunderland, R., Cross, K. W. & Ross, A. M. Declining incidence of episodes of asthma: a study of trends in new episodes presenting to general practitioners in the period 1989–98. Thorax 55, 657–661 (2000).
Hoare, J., Bruce, M. & Majeed, A. Prevalence of treated asthma and its management in general practice in England and Wales, 1994–1998. Health Stat. Q. 17, 15–22 (2003).
Vandevoorde, J. et al. Early detection of COPD: a case finding study in general practice. Respir. Med. 101, 525–530 (2007).
MIDAS Sales Data, IMS Health, April 2007.
IMS Health. Leading Products by Global Pharmaceutical Sales, 2006. IMS Health web site [online], (2006).
Adams, C. P., Branter, V. V. Estimating the cost of new drug development: is it really 802 million dollars? Health Aff. 25, 420–428 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Oversteegen, L., Rovini, H. & Belsey, M. Respiratory drug market dynamics. Nat Rev Drug Discov 6, 695–696 (2007). https://doi.org/10.1038/nrd2401
Issue date:
DOI: https://doi.org/10.1038/nrd2401
